M. Kraus & Co’s Eli Lilly LLY Stock Holding History

M. Kraus & Co’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.08M	Sell	901 -25	-3%	-$25.5K	0.29%	41
2026 Q1	$852K	Hold	926	–	–	0.25%	42
2025 Q4	$995K	Sell	926 -34	-4%	-$32.5K	0.28%	44
2025 Q3	$732K	Hold	960	–	–	0.2%	49
2025 Q2	$748K	Sell	960 -25	-3%	-$19.4K	0.22%	49
2025 Q1	$814K	Hold	985	–	–	0.25%	45
2024 Q4	$760K	Hold	985	–	–	0.23%	46
2024 Q3	$873K	Hold	985	–	–	0.26%	42
2024 Q2	$892K	Sell	985 -29	-3%	-$23.2K	0.27%	41
2024 Q1	$789K	Sell	1,014 -15	-1%	-$10.7K	0.24%	42
2023 Q4	$600K	Sell	1,029 -59	-5%	-$34.4K	0.2%	46
2023 Q3	$584K	Hold	1,088	–	–	0.21%	46
2023 Q2	$510K	Sell	1,088 -5	-0.5%	-$2.1K	0.17%	48
2023 Q1	$375K	Sell	1,093 -4	-0.4%	-$1.35K	0.13%	58
2022 Q4	$401K	Buy	1,097 +406	+59%	+$144K	0.15%	55
2022 Q3	$223K	Buy	+691	New	+$219K	0.09%	65

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

M. Kraus & Co's LLY Position: Q2 2026 in Review

M. Kraus & Co reduced its Eli Lilly (LLY) stake by 2.7% in Q2 2026, selling an estimated $25.5K and leaving 901 shares worth $1.08M. The position accounts for 0.29% of the portfolio, ranked #41.

M. Kraus & Co first reported a position in LLY in Q3 2022 and has held it in 16 quarters since. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

M. Kraus & Co held 901 shares of Eli Lilly worth $1.08M as of Q2 2026.
M. Kraus & Co sold 25 Eli Lilly shares in Q2 2026, an estimated $25.5K.
Eli Lilly made up 0.29% of M. Kraus & Co's portfolio in Q2 2026, its #41 holding.
M. Kraus & Co first reported a position in Eli Lilly in Q3 2022 and has held it in 16 quarters since.
4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on M. Kraus & Co's 13F filing for Q2 2026, filed 29 Jul 2026.